Clinical Trial Update: Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation

View source ↗

Summary

Observational clinical trial update evaluating ursodeoxycholic acid in patients with non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: General University Hospital, Prague | Conditions: Non-Alcoholic Fatty Liver Disease | Status: ACTIVE_NOT_RECRUITING